Citation Impact
Citing Papers
Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
2012
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Immune Rejection of Mouse Tumors Expressing Mutated Self
2009 StandoutNobel
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects
2005
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles
2022
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4 + CTL
2005
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Cutting Edge: NKG2ChiCD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein–Barr Virus
2014
The Oncogenic Potential of Hepatitis C Virus NS5A Sequence Variants Is Associated with PKR Regulation
2005
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
Linking CMV Serostatus to Episodes of CMV Reactivation Following Lung Transplantation by Measuring CMV-Specifi cCD8+ T-Cell Immunity
2008
Pretransplant Immediately Early-1-Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation
2013
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
2010 Standout
An Interventional Study Using Cell-Mediated Immunity to Personalize Therapy for Cytomegalovirus Infection After Transplantation
2017
Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
2010
Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design
2016
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Functional Impairment of Cytomegalovirus Specific CD8 T Cells Predicts High-Level Replication After Renal Transplantation
2008
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
2009
Regulation of microRNA biogenesis
2014 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients
2012
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
2012
Comparative Analysis of Assays for Detection of Cell-Mediated Immunity Toward Cytomegalovirus and M. tuberculosis in Samples From Deceased Organ Donors
2014
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
2004
The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional Approach
2018
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Programmed Death–1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease
2007
NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs
2005
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
2018
Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy
2014
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Graft-versus-host disease
2009 Standout
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia
2011
The dsRNA protein kinase PKR: Virus and cell control
2007
Cancer immunotherapy comes of age
2011 StandoutNature
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Structure and Function of the Protein Kinase R
2007
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients
2017
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Periodontal diseases
2017 Standout
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation
2016
Induction of Pluripotent Protective Immunity Following Immunisation with a Chimeric Vaccine against Human Cytomegalovirus
2008
Comparison of the Effect of Standard and Novel Immunosuppressive Drugs on CMV-Specific T-Cell Cytokine Profiling
2012
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules
2006
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Interferon-stimulated genes and their antiviral effector functions
2011 StandoutNobel
Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: A proof of principle
2012
Human Cytomegalovirus (HCMV)-Specific CD4+ and CD8+ T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
2014
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Biogenesis of small RNAs in animals
2009 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women
2015
Pretransplant Interferon-γ Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation
2013
ATP-Dependent Effector-like Functions of RIG-I-like Receptors
2015 StandoutNobel
Interferon Action and the Double‐Stranded RNA‐Dependent Enzymes ADAR1 Adenosine Deaminase and PKR Protein Kinase
2006
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
2017
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Treatment of cytomegalovirus infection and disease pre‐ and post‐quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?
2015
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
2012
An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity
2017
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
The CD8+T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus
2007
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors
2008
Bias in the αβ T‐cell repertoire: implications for disease pathogenesis and vaccination
2011
Epitope Landscape in Breast and Colorectal Cancer
2008 StandoutNobel
Inflammatory Mechanisms in Obesity
2011 Standout
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease
2005
Preformed Frequencies of Cytomegalovirus (CMV)–Specific Memory T and B Cells Identify Protected CMV-Sensitized Individuals Among Seronegative Kidney Transplant Recipients
2014
Increased Susceptibility to DNA Virus Infection in Mice with a GCN2 Mutation
2011 StandoutNobel
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
2019
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
NSs Protein of Rift Valley Fever Virus Induces the Specific Degradation of the Double-Stranded RNA-Dependent Protein Kinase
2009
The “Silent” Global Burden of Congenital Cytomegalovirus
2013
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
2006
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
2016
Vaccines: the Fourth Century
2009
Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope
2006
Periodontal herpesviruses: prevalence, pathogenicity, systemic risk
2015
Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus Infection
2011
Adoptive T‐cell immunotherapy for ganciclovir‐resistant CMV disease after lung transplantation
2015
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus
2007
Works of Tania Crough being referenced
Clinical Assessment of Anti-Viral CD8+ T Cell Immune Monitoring Using QuantiFERON-CMV® Assay to Identify High Risk Allogeneic Hematopoietic Stem Cell Transplant Patients with CMV Infection Complications
2013
Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON®‐CMV
2007
Modulation of human Vα24+Vβ11+ NKT cells by age, malignancy and conventional anticancer therapies
2004
Cross‐reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H
2004
Ex vivo expansion of human cytomegalovirus‐specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy
2005
Successful Immunotherapy of HCMV Disease Using Virus‐Specific T Cells Expanded from an Allogeneic Stem Cell Transplant Recipient
2009
Loss of PKR activity in chronic lymphocytic leukemia
2004
Contemporaneous fluctuations in T cell responses to persistent herpes virus infections
2004
Symptomatic and Asymptomatic Viral Recrudescence in Solid-Organ Transplant Recipients and Its Relationship with the Antigen-Specific CD8 + T-Cell Response
2007
Granulocyte Colony-Stimulating Factor Modulates α-Galactosylceramide-Responsive Human Vα24+Vβ11+ NKT Cells
2004
Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation
2009
Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers
2003
Narrowing of T‐cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients
2009
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
2009